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Introduction
Cell polarity is essential for many cells of metazoans, as exempli-
fi  ed by the axons and dendrites of developing neurons, the apical 
and basolateral domains of epithelial cells, and the morpho-
logically distinct front and back of migrating cells, such as che-
motaxing neutrophils. The RhoGTPases RhoA, Rac, and Cdc42 
regulate cell polarity (Fukata et al., 2003; Raftopoulou and Hall, 
2004) and are activated under spatial and temporal control by more 
than 70 guanine nucleotide exchange factors (GEFs) of the Rho 
GEF family (Rossman et al., 2005). To understand regulation of 
cell polarity, it is necessary to identify the relevant Rho GEFs, 
their target Rho GTPases, and their location of activation.
In differentiated HL60 (dHL60) cells, a neutrophil-like 
cell line, stimulation with a chemoattractant, such as the tri-
peptide formyl-Met-Leu-Phe (fMLP), induces cell polarity (Hauert 
et al., 2002). Symmetry is broken by activating divergent signaling 
pathways for controlling the formation of front and back (Xu et al., 
2003; Wong et al., 2006). Signals downstream of Gi, phospati-
dylinositol-3′-kinase (PI3K), Rac, and F-actin participate in 
positive feedback loops that mediate protrusive actin assembly at 
the front (Niggli, 2000; Wang et al., 2002; Weiner et al., 2002). 
At the back, G12 and 13 promote activation of RhoA and its down-
stream mediators, a Rho-dependent kinase (ROCK) and myosin II, 
resulting in formation of contractile actomyosin complexes (Xu 
et al., 2003).
Together, these divergent pathways constitute a self-
organizing mechanism that allows dHL60 cells to polarize with-
out a spatial cue—that is, after stimulation with a spatially uniform 
concentration of chemoattractant (Shields and Haston, 1985; 
Xu et al., 2003; Wong et al., 2006). After uniform stimulation, 
frontness- and backness-promoting activities initially overlap at 
the cell periphery but then segregate to form a single front and 
a single back (Xu et al., 2003; Wong et al., 2006). Cells lacking 
phospatidylinositol-3,4,5-tris-phosphate (PIP3) or Cdc42 signaling 
exhibit unstable polarity, characterized by transient but multiple 
fronts and backs (Van Keymeulen et al., 2006). We proposed 
that signals for the front, PIP3 and Cdc42, enhance both front and 
back signals (Van Keymeulen et al., 2006), perhaps by locally 
regulating Rac GEFs in the pseudopod at the front while increasing 
activities of RhoA GEFs at longer range to suppress formation 
of lateral pseudopods at the back and sides.
Recent studies demonstrated that PIX-α and DOCK2, 
GEFs for Cdc42 and Rac2, respectively, are recruited to the 
plasma membrane by PIP3 in response to chemoattractant stimu-
lation (Li et al., 2003; Kunisaki et al., 2006). Mouse neutrophils 
lacking PIX-α, similar to those lacking PI3Kγ (Hirsch et al., 2000; 
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hemoattractants such as formyl-Met-Leu-Phe (fMLP) 
induce neutrophils to polarize by triggering diver-
gent pathways that promote formation of a protru-
sive front and contracting back and sides. RhoA, a 
Rho GTPase, stimulates assembly of actomyosin contractile 
complexes at the sides and back. We show here, in differ-
entiated HL60 cells, that PDZRhoGEF (PRG), a guanine 
nucleotide exchange factor (GEF) for RhoA, mediates 
RhoA-dependent responses and determines their spatial 
distribution. As with RNAi knock-down of PRG, a GEF-
deleted PRG mutant blocks fMLP-dependent RhoA activa-
tion and causes neutrophils to exhibit multiple fronts and 
long tails. Similarly, inhibition of RhoA, a Rho-dependent 
protein kinase (ROCK), or myosin II produces the same 
morphologies. PRG inhibition reduces or mislocalizes mono-
phosphorylated myosin light chains in fMLP-stimulated 
cells, and myosin II ATPase inhibition reciprocally disrupts 
normal localization of PRG. We propose a cooperative 
reinforcing mechanism at the back of cells, in which PRG, 
RhoA, ROCK, myosin II, and actomyosin spatially cooperate 
to consolidate attractant-induced contractility and ensure 
robust cell polarity.
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Li et al., 2000; Hannigan et al., 2002), exhibit defective chemo-
taxis in chemoattractant gradients (Li et al., 2003). DOCK2-
defi  cient mouse neutrophils fail to accumulate F-actin and PIP3 
at the leading edge and show abnormal polarity and migration 
(Kunisaki et al., 2006).
Lsc (also known as p115RhoGEF) has been reported 
(Francis et al., 2006) to activate neutrophil RhoA in response to 
attractant stimulation and is required for integrin-dependent 
adhesion. Lsc-defi  cient mouse neutrophils fail to polarize with a 
single pseudopod and show reduced directionality. Lsc localization 
at the leading edge (Francis et al., 2006), however, does not mimic 
the distribution of active RhoA (Xu et al., 2003; Wong et al., 2006), 
suggesting that other GEFs participate in regulation of RhoA 
at the sides and back. PDZRhoGEF (PRG), which contains a 
G12/13-coupled RGS domain and a GEF domain known to 
activate RhoA (Fukuhara et al., 1999; Rumenapp et al., 1999), 
represents an appealing candidate regulator for RhoA-dependent 
backness. PRG plays essential roles in polarity of neurons and cili-
ated epithelia (Swiercz et al., 2002; Basile et al., 2004; Longhurst 
et al., 2006; Panizzi et al., 2007). Its Drosophila orthologue in 
S2 cells, DRhoGEF2, localizes to plus ends of microtubules for 
delivery to the cell periphery (Rogers et al., 2004). In the pres-
ence of active Concertina, a G12/13 orthologue, DRhoGEF2 is 
released from microtubules to activate RhoA at the cell membrane, 
Figure 1.  Expression and localization of PRG in dHL60 cells. (A) Lysates from nondifferentiated dHL60 cells (ND) or cells differentiated for 7 d (D7) were 
immunoblotted for PRG protein. RhoA was used as a loading control. (B) DIC and ﬂ  uorescent time-lapse images of a live dHL60 cell transfected with 
PRG-YFP. Time indicates elapsed time after uniform addition of 100 nM fMLP at 0:00. (C) DIC and ﬂ  uorescent images of a representative polarized cell 
showing PRG-YFP (green) and actin (red). Cells transfected with PRG-YFP were stimulated with 100 nM fMLP for 3 min, ﬁ  xed, and stained for F-actin. 
Arrowheads outline pseudopod; arrow depicts the cell’s back. Bar = 10 μm.PDZRHOGEF IN NEUTROPHILS • WONG ET AL. 1143
thereby generating actomyosin-dependent contraction (Rogers 
et al., 2004). Here, we show that PRG mediates activation of 
G12/13-RhoA-dependent backness and is necessary for polar-
ization of dHL60 cells. We describe a cooperative mechanism 
in which back-promoting signals and the resulting contraction of 
actomyosin spatially confi  ne one another, consolidating backness 
signals to ensure robust cell polarity.
Results and discussion
Expression and localization of PRG
Peripheral blood leukocytes contain PRG mRNA (Fukuhara 
et al., 1999), and PRG protein is expressed much more strongly 
in differentiated HL60 cells than undifferentiated cells (Fig. 1 A). 
This differentiation-induced expression resembles that of other 
polarity components, such as Hem1 (unpublished data), and prob-
ably contributes to neutrophil-like properties of differentiated 
HL60 cells.
PRG’s spatial distribution during polarization shows that it 
is present in the right place at the right time to function as a 
potential regulator of RhoA during fMLP-induced polarization. 
The PRG-specifi  c antibody failed to detect specifi  c immuno-
fl  uorescence staining. To determine the localization of PRG, 
we transiently expressed PRG-YFP. High expression of PRG-
YFP, assessed by degree of cell fl  uorescence, correlated with a 
rounded cell morphology (unpublished data) similar to that induced 
by dominant-positive RhoA (Xu et al., 2003). To obtain low 
expression of PRG, we used cells at 3 h post-transfection or 
expressed PRG-YFP under a leaky tetracycline-inducible promoter 
in the absence of tetracycline. Time-lapse fl  uorescent images 
show that PRG-YFP is partly cytosolic but is located mostly at 
the cell periphery. fMLP causes PRG-YFP, localized uniformly 
at the periphery of resting cells, to shift to a back-concentrated 
distribution in polarized cells (86% of cells examined, n = 42; 
Fig. 1, B and C). PRG is markedly excluded from the actin-rich 
front and partially colocalizes with actin at the back (Fig. 1 C). 
The increased actin at the back probably refl  ects local elevation 
of actomyosin complexes caused by increased RhoA activity.
PRG is necessary for fMLP-induced polarity 
and RhoA activation
To study PRG’s function in polarization in dHL60 cells, we used 
a lentiviral-mediated short hairpin RNA (shRNA) to knock down 
its expression. PRG protein is dramatically reduced in knock-
down (KD) cells (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200706167/DC1).
PRG is required for fMLP-induced polarity in dHL60 
cells. In contrast to control cells, which polarize with a single 
actin-rich pseudopod and a single retracting back (Fig. 2; Fig. 
S1 B), PRG KD cells often show multiple pseudopods or long 
tails (Fig. 2; S1 B) and migrate with reduced speed and persis-
tence (Fig. S1 C). Inactivation of RhoA, ROCK, or myosin II 
ATPase in dHL60 cells induced similar morphologies (Xu et al., 
2003). Re-introduction of a myc-tagged rat PRG orthologue 
(Myc-rPRG; identifi  ed by RFP coexpression) rescues the KD 
phenotype (Fig. S1, B–D), suggesting that PRG mediates the 
fMLP-induced activation of myosin II by activating RhoA.
PRG’s DH-PH domain is required for its localization to the 
back and function during polarization. Expression of a DH-PH 
deleted mutant (1–735 aa; Fig. S2 A, available at http://www
.jcb.org/cgi/content/full/jcb.200706167/DC1), which has been 
shown to lack GEF activity in other cell types (Fukuhara et al., 1999; 
Figure 2.  PRG depletion disrupts fMLP-induced polarity. 
DIC time-lapse images of dHL60 cells expressing luciferase-
targeted control or PRG-targeted shRNA. (Right) DIC and 
ﬂ  uorescent overlays of control and PRG KD cells processed 
as in Fig. 1 C. Time indicates elapsed time after uniform 
stimulation with 100 nM fMLP. Different arrowhead colors 
indicate separate pseudopod. Bars = 10 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1144
Driessens et al., 2002; Banerjee and Wedegaertner, 2004), causes 
a phenotype similar to that induced by shRNA-mediated KD of 
PRG (7/8 cells examined; Fig. S2 B). In contrast to the back-
enriched localization of wild-type PRG-YFP, this YFP-tagged 
mutant (1–735-YFP) localizes to actin-rich pseudopods, which 
are often multiple (Fig. S2, B and B′).
Unlike the 1–735-YFP construct, expression of N-terminal 
deletion mutants lacking the PDZ or the PDZ plus the RGS 
(128–1522 or 435–1522; Fig. S2 A) domains does not affect 
formation of polarity, but does destabilize polarity in some 
cells: the region occupied by a front becomes a back and vice 
versa, resulting in reversal of polarity (6/11 cells for 128–1522, 
4/10 cells for 435–1522; example in Fig. S2 C). In contrast to 
the stable polarity maintained throughout the course of imaging 
in cells expressing wild-type PRG-YFP (7/8 cells; Fig. 1 B), 
cells expressing either of these N-terminal deletion mutants ac-
cumulate mutant PRG-YFP at both the front and the back (Fig. 
S2, C and C′; arrowheads and arrows). These results suggest 
that normally the PDZ domain, in the presence of DH-PH do-
main, keeps the protein at the back. Therefore, restrictive local-
ization of PRG is necessary to establish and maintain dHL60 
cell polarity in response to fMLP, probably by regulating the 
RhoA-dependent back-promoting pathway.
PRG is necessary for fMLP to induce activation of RhoA, 
as documented by an assay (Niggli, 2003) that assesses associa-
tion of RhoA with the particulate fraction of cells previously ex-
posed to fMLP. As previously reported, fMLP increases RhoA 
in the particulate fraction of extracts from neutrophils or dHL60 
cells (Niggli, 2003; Van Keymeulen et al., 2006). The attractant 
fails to do so, however, in PRG KD cells (Fig. 3 A). Similarly, a 
fl  uorescence resonance energy transfer (FRET)–based assay for 
measuring RhoA activity (Wong et al., 2006) shows that in cells 
coexpressing the RhoA biosensor and a myc-tagged 1–735 PRG 
(Myc-1–735), fMLP fails to increase RhoA FRET as previously 
reported in control cells (Wong et al., 2006; unpublished data).
To further characterize the role of PRG, we assessed the lo-
calization of monophosphorylated myosin light chain 2 (p-MLC2). 
Instead of the typical sides-and-back localization seen in fMLP-
stimulated control cells, KD cells defi  cient in endogenous PRG 
exhibit multiple heads with reduced or mislocalized p-MLC2 
(Fig. 3 B). Re-introduction of Myc-rPRG restores the cells’ abil-
ity to polarize, making a single actin-rich front (Fig. 3 B, green) 
and a single back enriched in p-MLC2 and Myc-rPRG (Fig. 3 B, 
red and blue panels). The increased actin staining at the back is 
similar to the effect of expressing PRG-YFP in wild-type cells 
(Fig. 1 C). Together, these results indicate that PRG consoli-
dates the front and back by regulating the RhoA-dependent back-
promoting pathway.
Similarly, dHL60 cells expressing Myc-1-735 show reduced 
or mislocalized staining of p-MLC2 that does not overlap with that 
of Myc-1–735 (Fig. S2 D). Like 1–735-YFP, Myc-1–735 localizes 
to ruffl  es. Typical morphologies and their relative frequencies 
are shown in Fig. S2 A. The reciprocal distribution patterns of 
p-MLC2 and Myc-1–735 suggest that Myc-1–735 PRG acts by se-
questering binding partners that normally interact with endogenous 
PRG to localize it at the back. One such partner could be G12/13, 
which may be sequestered by the RGS domain of Myc-1–735 PRG. 
Alternatively, the PDZ domain in the 1–735 construct might—as 
reported for rat PRG (Longhurst et al., 2006)—interact with type I 
PDZ ligands and light chains of microtubule-associated protein 1. 
In either case, this result implies that PRG in normal cells acts 
locally to activate RhoA and its downstream pathway, and—
reciprocally—that the local “backness” environment created by 
its GEF activity is necessary for its localization.
We note, however, that a subpopulation of PRG KD cells 
with multiple leading edges rich in F-actin still exhibit increased 
accumulation of p-MLC2 at a single site (Fig. 3 B). Because the 
level of p-MLC2 in KD cells is similar to that of controls, as 
  assayed by immunoblots (unpublished data), it is likely that PRG 
normally regulates localization rather than the total amount of 
MLC2 phosphorylation. Alternatively, cell-to-cell variation in 
expression of PRG shRNA may fail to deplete PRG effi  ciently 
in some cells. Myosin II could be activated by other mecha-
nisms as well, involving RhoA GEFs such as Lsc (Francis et al., 
2006) as well as RhoA-independent pathways.
G12/13 and myosin II spatially regulate PRG
To ask whether PRG mediates signal transmission between 
G12/13 and RhoA in response to fMLP, we coexpressed dominant-
negative (DN) or constitutively active (CA) mutants of G12/13 
together with PRG-YFP in dHL60 cells and assessed localiza-
tion of PRG-YFP. As previously reported (Xu et al., 2003), 
cells expressing DN G12 and G13 form multiple leading edges 
(Fig. 4 A, arrowheads). Moreover, G12/13 regulates the spatial 
distribution of PRG. Instead of localizing to the cell periphery 
at the back as in control cells (Fig. 4 A), punctate clusters of PRG 
distribute throughout cells coexpressing DN G12 and G13, es-
pecially around the nucleus (Fig. 4 A). On the other hand, ex-
pression of CA G12 and G13 or RhoA (unpublished data) causes 
cells to round up, with PRG-YFP localized around the entire 
periphery (Fig. 4 A).
To determine whether myosin II, a downstream target of 
the G12/13-RhoA pathway, is involved in regulating PRG, we 
inhibited its ATPase activity with blebbistatin. As previously 
shown, blebbistatin causes fMLP-stimulated cells to make mul-
tiple leading edges or a long tail (Xu et al., 2003). Just as in cells 
expressing DN G12/13, PRG-YFP in blebbistatin-treated cells 
localizes in clusters around the nucleus (Fig. 4 A). Inhibiting 
ROCK with Y-27632 (Narumiya et al., 2000) causes the same 
phenotype (unpublished data), in keeping with the notion that 
ROCK acts upstream of myosin II (Xu et al., 2003). These re-
sults suggest that localization of PRG depends on myosin II 
activity. The observed distribution is not due to background 
fl  uorescence from blebbistatin; comparing blebbistatin-treated 
nontransfected cells with transfected cells revealed no notice-
able signal in the nontransfected population (Fig. S3, available 
at http://www. jcb.org/cgi/content/full/jcb.200706167/DC1).
Although myosin II helps to localize PRG, and vice versa, 
the underlying biochemical mechanisms remain unknown. Back-
ness signals could spatially regulate PRG by somehow directing 
the transport of PRG-containing vesicles, as suggested by the 
Golgi-like perinuclear punctate distribution of PRG-YFP in cells 
disrupted for RhoA-dependent backness signals (Fig. 4 A). 
Indeed, nonmuscle myosin II is known to be important for the PDZRHOGEF IN NEUTROPHILS • WONG ET AL. 1145
Figure 3.  PRG mediates fMLP-induced RhoA activation and consolidation of front and back. (A) fMLP-induced membrane association of RhoA. Control or 
KD cells were stimulated with or without fMLP (100 nM, 1 min) as indicated. RhoA associated with the particulate fraction of cell extracts was assessed as 
described. A representative immunoblot and quantiﬁ  cation of immunoblotted bands are shown. For each immunoblot, background signal was subtracted 
and the level of RhoA normalized to that of transferrin receptor in the particulate fraction; all values were further normalized to the signal detected in the 
unstimulated control, set at 1.0. Bar represents the average of four independent experiments, with different symbols representing the actual values. P values 
are shown. **, P ≤ 0.05. (B) DIC and ﬂ  uorescent images of representative cells expressing control or PRG-targeted shRNA with or without a Myc-tagged 
rat PRG processed as in Fig. 1 C and stained for actin (green), p-MLC2 (red), and Myc (blue). Bars = 10 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1146
Figure 4.  Spatial distribution of PRG depends on G12/13 and myosin II. (A) dHL60 cells transiently transfected with PRG-YFP alone, or together with 
DN or CA G12 and G13 were stimulated with 100 nM fMLP, ﬁ  xed, and imaged. Representative DIC and ﬂ  uorescent images of each group are shown. 
Cells expressing PRG-YFP alone with or without 45 min pretreatment with 100 μM blebbistatin were processed and imaged as above. Percent of cells with 
mislocalized PRG-YFP was plotted for control (n = 60), KD cells expressing rat PRG (rescued; n = 36), cells coexpressing DN G12/13 (n = 33), CA G12/13 
(n = 28), or CA RhoA (n = 31) and cells treated for 45 min with 100 μM blebbistatin (n = 46), 10 μM Y-27632 (n = 29), 1 μM PIK-90 (n = 37), or 
25 μM nocodazole (n = 47). (B) Quantiﬁ  cation of mean FRET/CFP ratio in RhoA biosensor cells treated with or without Y-27632 (10 μM, 45 min), stimulated 
and processed as above. Mean FRET/CFP ratios ± SEM (error bar) in unstimulated (n = 23) and stimulated (n = 26) control, unstimulated (n = 24) 
and stimulated (n = 27) Y-27632-treated cells are 1 ± 0.03, 1.3 ± 0.02, 1.17 ± 0.03, and 1.22 ± 0.03, respectively. P values are as indicated. PDZRHOGEF IN NEUTROPHILS • WONG ET AL. 1147
directional transport of vesicles in polarized systems such as 
epithelial cells (Stow et al., 1998). Because RhoA signaling is 
involved in cell adhesion (Arthur et al., 2002), adhesion com-
ponents may also be coupled to the spatial regulation of PRG 
containing-vesicles.
While myosin II regulates the localization of PRG, it may 
not be necessary for fMLP to activate RhoA, as suggested by 
the effect of inhibiting ROCK with Y-27632 (Fig. 4 B). We used 
Y-27632, rather than blebbistatin, to block fMLP-induced 
ROCK-dependent activation of myosin II (this avoids interfer-
ence by blebbistatin fl  uorescence with RhoA FRET). In cells 
quasi-stably expressing the RhoA biosensor (Wong et al., 2006), 
inhibiting ROCK and therefore myosin II does not reduce RhoA 
activity (Fig. 4 B). Instead, ROCK-inhibited cells show elevated 
basal RhoA FRET compared with unstimulated controls and 
fMLP fails to further increase the level of active RhoA (Fig. 4 B). 
The RhoA FRET signal, like PRG-YFP in ROCK-inhibited 
cells, is highest around the nucleus, in contrast to the back local-
ization in controls (Fig. 4 C; the nucleus is visible because it 
excludes the RhoA biosensor).
The fi  ndings that myosin II regulates PRG by spatially fo-
cusing its activity rather than by controlling its level of activity 
suggest a mechanism in which G12/13, PRG, RhoA, and myosin II 
cooperate to spatially self-confi  ne and concentrate backness-
promoting signals. In addition to G12/13 and myosin II, two other 
reported mechanisms may help confi  ne PRG to the back and ex-
clude it from the front: PRG’s interaction with F-actin has been sug-
gested to suppress its GEF activity (Banerjee and Wedegaertner, 
2004), and PAK4, an effector of Cdc42, has been reported (Barac 
et al., 2004) to phosphorylate PRG and inhibit its activity.
Positive feedback loops for the front, involving PIP3, Rac, 
and protrusive actin, activate and reinforce one another to form 
and ensure a robust front (Wang et al., 2002; Weiner et al., 2002). 
Now we identify a mechanism in which backness components 
G12/13, PRG, RhoA, ROCK, myosin II, and actomyosin spatially 
consolidate and strengthen one another at the back. Together with 
the mutual exclusivity between front and back activities (Xu et al., 
2003), these two divergent signaling pathways create distinct 
  subcellular environments that favor the propagation of their own 
signals, thereby facilitating their segregation from one another 
during symmetry breaking.
PIP3 and microtubules are both reported to regulate back-
ness (Niggli, 2003; Xu et al., 2005; Van Keymeulen et al., 2006), 
but our experiments so far do not allow us to draw fi  rm inferences 
regarding the possible role of microtubules in regulating localiza-
tion of PRG-YFP (see Online supplemental materials, available 
at http://www.jcb.org/cgi/content/full/jcb.200706167/DC1).
Materials and methods
Constructs and antibodies
Myc-tagged human PRG and its deletion mutants were gifts from Philip 
Wedegaertner (Thomas Jefferson University, Philadelphia, PA). C-terminally 
YFP-tagged human full-length and mutant PRG were generated by PCR us-
ing the myc-tagged constructs as templates and the resulting PCR fragments 
cloned into EcoRI and SalI sites in pEYFP-C1. The tetracycline-inducible con-
struct was generated by inserting PRG-YFP into pTRE (Clontech Laboratories, 
Inc.). Myc-tagged rat PRG was a gift from Mandy Jackson (University of Ed-
inburgh, Edinburgh, UK). The RhoA biosensor construct used for transient 
transfection was as described (Pertz et al., 2006). G12-DN and G13-DN 
constructs (residues 326–379 for Gα12, and residues 321–377 for Gα13) 
were as described (Sugimoto et al., 2003). CA mutants of Gα12 and 
Gα13 were obtained from Guthrie Institute (Sayre, PA). Lentiviral shRNA 
construct targeting human PRG was generated by cloning a 5′-tcaacgctgt-
gtcattatccaa-3′ sequence into pPRIME-CMV-GFP-FF3 according to the proto-
col for pPRIME (Stegmeier et al., 2005). This construct contained GFP for 
identiﬁ  cation of shRNA expression. An empty pPRIME-CMV-GFP-FF3 vector 
that contained GFP and hairpin targeting ﬁ  reﬂ  y luciferase was used as a 
control. Rabbit polyclonal antibody against PRG was a gift from John Roth-
stein (The Johns Hopkins University, Baltimore, MD). Mouse monoclonal an-
tibody against myosin light chain 2 phosphorylated at S19 (p-MLC2) was 
from Cell Signaling Technology. Antibodies against RhoA, and c-myc were 
from Santa Cruz Biotechnology, Inc. Blebbistatin and PIK-90 were gifts from 
Tim Mitchison (Harvard University, Boston, MA) and Kevan Shokat (University 
of California, San Francisco, San Francisco, CA), respectively. Y-27632 and 
nocodazole were from Calbiochem. Alexa350- and rhodamine-phalloidin 
were obtained from Molecular Probes. Human ﬁ  bronectin was from BD 
Biosciences. Nocodazole, protease and phosphatase inhibitor cocktails 
and fMLP were from Sigma-Aldrich. Horseradish peroxidase–conjugated 
donkey anti–rabbit and anti–mouse IgG, FITC or rhodamine-conjugated 
anti–rabbit and anti–mouse IgG were from GE Healthcare.
Cell culture, transient transfection, and lentiviral expression
HL60 cells were cultivated, differentiated, and transiently transfected as 
previously described (Servant et al., 2000; Srinivasan et al., 2003); exper-
iments were performed 3–4 h after transfection unless otherwise indicated. 
Quasi-stable expression of control and PRG shRNAs was accomplished by 
lentiviral transfection and infected cells were FAC sorted for GFP expression 
as described (Wong et al., 2006).
Microscopy
Live dHL60 cells on coverslips in 1.5% human albumin in mHBSS or ﬁ  xed 
cells in PBS were imaged at room temperature using an inverted micro-
scope (Eclipse TE2000-E; Nikon) equipped with a Photometrics CoolSnap 
HQ CCD camera (Roper Scientiﬁ  c) driven by MetaMorph software (MDS 
Analytical Technologies). Pictures shown were taken with a 40× NA1.30 
oil S Fluor objective (Nikon). Fluorochromes used include YFP, CFP, RFP, 
rhodamine, Alexa350, Texas red, and FITC. Cells were tracked using 
MetaMorph software (MDS Analytical Technologies).
FRET analysis
Cells transiently transfected with the RhoA biosensor were stimulated with 
or without 100 nM fMLP for 3 min, ﬁ  xed, and imaged as described (Wong 
et al., 2006). FRET data were processed and subjected to statistical analysis 
as described (Wong et al., 2006). Unless stated otherwise, values from at 
least 14 cells were used to assess mean FRET/CFP ratios for each condition. 
Each set of experiment was repeated at least three times.
Assay for particulate-associated RhoA
Procedure and analysis for this assay were as described (Van Keymeulen 
et al., 2006).
Actin and immunoﬂ  uorescence staining
Procedures for actin staining and immunoﬂ  uorescence have been described 
(Xu et al., 2003; Van Keymeulen et al., 2006).
Online supplemental material
Figure S1 shows that depletion of PRG causes migratory defects. 
Figure S2 shows how disrupted PDZRhoGEF function disrupts fMLP-induced 
polarity. Figure S3 shows background ﬂ   uorescence of blebbistatin. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200706167/DC1.
Similar results were observed in three independent experiments. **, P ≤ 0.05. (C) Representative DIC, CFP, and FRET/CFP ratio images of control and 
Y-27632–treated cells. Ratio images were scaled relative to each other. Warm color = high value, cold color = low value. Different color of arrowheads 
marks different pseudopod. Bars = 10 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1148
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